<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>5533</number>
    <updateDate>2023-01-13T04:50:51Z</updateDate>
    <updateDateIncludingText>2023-01-13T04:50:51Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2006-06-06</introducedDate>
    <congress>109</congress>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2006-11-13T21:46:49Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2006-06-23T14:29:46Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2006-09-26T22:40:10Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2006-09-20T14:05:17Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2006-06-06T18:01:20Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 109-686</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Biodefense and Pandemic Vaccine and Drug Development Act of 2006</title>
        <congress>109</congress>
        <number>2564</number>
        <type>S</type>
        <latestAction>
          <actionDate>2006-04-06</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S3222-3227)</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Biodefense and Pandemic Vaccine and Drug Development Act of 2005</title>
        <congress>109</congress>
        <number>1873</number>
        <type>S</type>
        <latestAction>
          <actionDate>2005-10-24</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 257.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>House</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2006-11-13</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2006-09-27</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <actionTime>20:01:56</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <actionTime>20:01:52</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7445-7447)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <actionTime>20:01:52</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7445-7447)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <actionTime>19:47:47</actionTime>
        <text>DEBATE - The House proceeded with forty mintues of debate on H.R. 5533.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <actionTime>19:47:44</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H7445-7450)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <actionTime>19:47:24</actionTime>
        <text>Mr. Deal (GA) moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 416.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00416</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 109-686.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2006-09-26</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 109-686.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2006-09-20</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2006-09-20</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2006-06-23</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2006-06-06</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2006-06-06</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-06-06</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>R000572</bioguideId>
        <fullName>Rep. Rogers, Mike J. [R-MI-8]</fullName>
        <firstName>Mike</firstName>
        <lastName>Rogers</lastName>
        <party>R</party>
        <state>MI</state>
        <district>8</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>E000215</bioguideId>
        <fullName>Rep. Eshoo, Anna G. [D-CA-14]</fullName>
        <firstName>ANNA</firstName>
        <lastName>ESHOO</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>G.</middleName>
        <district>14</district>
        <sponsorshipDate>2006-06-06</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H000676</bioguideId>
        <fullName>Rep. Hoekstra, Peter [R-MI-2]</fullName>
        <firstName>PETER</firstName>
        <lastName>HOEKSTRA</lastName>
        <party>R</party>
        <state>MI</state>
        <district>2</district>
        <sponsorshipDate>2006-06-06</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M000472</bioguideId>
        <fullName>Rep. McHugh, John M. [R-NY-23]</fullName>
        <firstName>JOHN</firstName>
        <lastName>MCHUGH</lastName>
        <party>R</party>
        <state>NY</state>
        <middleName>M.</middleName>
        <district>23</district>
        <sponsorshipDate>2006-06-06</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001248</bioguideId>
        <fullName>Rep. Burgess, Michael C. [R-TX-26]</fullName>
        <firstName>Michael</firstName>
        <lastName>Burgess</lastName>
        <party>R</party>
        <state>TX</state>
        <middleName>C.</middleName>
        <district>26</district>
        <sponsorshipDate>2006-06-07</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>J000070</bioguideId>
        <fullName>Rep. Jefferson, William J. [D-LA-2]</fullName>
        <firstName>WILLIAM</firstName>
        <lastName>JEFFERSON</lastName>
        <party>D</party>
        <state>LA</state>
        <middleName>J.</middleName>
        <district>2</district>
        <sponsorshipDate>2006-06-15</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C000537</bioguideId>
        <fullName>Rep. Clyburn, James E. [D-SC-6]</fullName>
        <firstName>JAMES</firstName>
        <lastName>CLYBURN</lastName>
        <party>D</party>
        <state>SC</state>
        <middleName>E.</middleName>
        <district>6</district>
        <sponsorshipDate>2006-06-19</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001036</bioguideId>
        <fullName>Rep. Capps, Lois [D-CA-23]</fullName>
        <firstName>LOIS</firstName>
        <lastName>CAPPS</lastName>
        <party>D</party>
        <state>CA</state>
        <district>23</district>
        <sponsorshipDate>2006-07-17</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000309</bioguideId>
        <fullName>Rep. Gordon, Bart [D-TN-6]</fullName>
        <firstName>BART</firstName>
        <lastName>GORDON</lastName>
        <party>D</party>
        <state>TN</state>
        <district>6</district>
        <sponsorshipDate>2006-07-28</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000364</bioguideId>
        <fullName>Rep. Shimkus, John [R-IL-19]</fullName>
        <firstName>JOHN</firstName>
        <lastName>SHIMKUS</lastName>
        <party>R</party>
        <state>IL</state>
        <middleName>M.</middleName>
        <district>19</district>
        <sponsorshipDate>2006-09-06</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>F000443</bioguideId>
        <fullName>Rep. Ferguson, Mike [R-NJ-7]</fullName>
        <firstName>MIKE</firstName>
        <lastName>FERGUSON</lastName>
        <party>R</party>
        <state>NJ</state>
        <district>7</district>
        <sponsorshipDate>2006-09-06</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000784</bioguideId>
        <fullName>Rep. Wynn, Albert Russell [D-MD-4]</fullName>
        <firstName>ALBERT</firstName>
        <lastName>WYNN</lastName>
        <party>D</party>
        <state>MD</state>
        <middleName>R.</middleName>
        <district>4</district>
        <sponsorshipDate>2006-09-19</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2006-09-26T04:00:00Z</pubDate>
        <title>H.R. 5533, Biodefense and Pandemic Vaccine and Drug Development Act of 2006</title>
        <url>http://www.cbo.gov/publication/18165</url>
        <description>&lt;p&gt;Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on September 20, 2006&lt;/p&gt;</description>
      </item>
      <item>
        <pubDate>2006-09-26T04:00:00Z</pubDate>
        <title>H.R. 5533, Biodefense and Pandemic Vaccine and Drug Development Act of 2006</title>
        <url>https://www.cbo.gov/publication/18165</url>
        <description>Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on September 20, 2006</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Access to health care</name>
        </item>
        <item>
          <name>Antibiotics</name>
        </item>
        <item>
          <name>Antitrust law</name>
        </item>
        <item>
          <name>Awards, medals, prizes</name>
        </item>
        <item>
          <name>Biological warfare</name>
        </item>
        <item>
          <name>Chemical warfare</name>
        </item>
        <item>
          <name>Commemorations</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Communicable diseases</name>
        </item>
        <item>
          <name>Communication in medicine</name>
        </item>
        <item>
          <name>Communication in science</name>
        </item>
        <item>
          <name>Conferences</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Economics and Public Finance</name>
        </item>
        <item>
          <name>Epidemics</name>
        </item>
        <item>
          <name>Executive reorganization</name>
        </item>
        <item>
          <name>Federal advisory bodies</name>
        </item>
        <item>
          <name>Federal aid to research</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Government procurement</name>
        </item>
        <item>
          <name>Government trust funds</name>
        </item>
        <item>
          <name>Health planning</name>
        </item>
        <item>
          <name>Laboratories</name>
        </item>
        <item>
          <name>Medical technology</name>
        </item>
        <item>
          <name>Medical tests</name>
        </item>
        <item>
          <name>Nuclear terrorism</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Radiation victims</name>
        </item>
        <item>
          <name>Research and development</name>
        </item>
        <item>
          <name>Research and development facilities</name>
        </item>
        <item>
          <name>Research centers</name>
        </item>
        <item>
          <name>Research grants</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Strategic planning</name>
        </item>
        <item>
          <name>Technological innovations</name>
        </item>
        <item>
          <name>Terrorism</name>
        </item>
        <item>
          <name>Vaccines</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2006-06-06</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2006-08-08T15:46:28Z</updateDate>
        <text><![CDATA[ <p>Biodefense and Pandemic Vaccine and Drug Development Act of 2006 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop and make public a strategic plan to integrate biodefense and emerging infectious disease requirements with the advanced research and development, strategic initiatives for innovation, and the procurement of qualified countermeasures and qualified pandemic or epidemic products.</p> <p>Establishes the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services (HHS).</p> <p>Requires the Secretary to: (1) coordinate and oversee the acceleration of countermeasure and product advanced research and development; and (2) delegate to the Director of BARDA any necessary functions and authorities.</p> <p>Establishes the Biodefense Medical Countermeasure Development Fund.</p> <p>Requires the Secretary to establish the National Biodefense Science Board to provide expert advice and guidance to the Secretary on matters relating to current and future chemical, biological, nuclear, and radiological agents.</p> <p>Prohibits payment on a security countermeasure procurement contract until the delivery of an acceptable portion of such product to the Secretary unless advance payment is necessary to ensure the success of the project. Requires the Secretary, where possible, to enter into multiple transactions for the procurement of multiple technologies and products from manufacturers of security countermeasures and qualified countermeasures.</p>]]></text>
      </summary>
      <summary>
        <versionCode>36</versionCode>
        <actionDate>2006-09-26</actionDate>
        <actionDesc>Passed House amended</actionDesc>
        <updateDate>2006-12-07T20:47:03Z</updateDate>
        <text><![CDATA[ <p>Biodefense and Pandemic Vaccine and Drug Development Act of 2006 - Amends the Public Health Service Act to establish the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services (HHS). Requires the Secretary of Health and Human Services to coordinate and oversee the acceleration of countermeasure and product advanced research and development.</p> <p>Requires the Secretary to: (1) facilitate and increase expeditious and direct communication with respect to such research and development; (2) conduct ongoing searches for, and support calls for, potential qualified countermeasures and qualified pandemic or epidemic products; (3) direct and coordinate such research and development activities of HHS; (4) establish strategic initiatives to accelerate such research and development and innovation in priority unmet need areas; and (5) connect interested persons with authorized offices or employees to advise such persons regarding relevant regulatory requirements related to qualified countermeasures or qualified pandemic or epidemic products. Allows the Secretary to award contracts, grants, and cooperative agreements or enter into other transactions to promote: (1) innovation in technologies that may assist such research and development; (2) research on and development of research tools and other devices and technologies; and (3) research to promote strategic initiatives, such as rapid diagnostics, broad spectrum antimicrobials, and vaccine manufacturing technologies.</p> <p>Authorizes the Secretary to enter into other transactions for countermeasure and product advanced research and development. Gives the Secretary expedited procurement authorities, the authority to expedite peer review, and the authority for personal services contracts. Authorizes the Secretary to require that, as a condition of being awarded a contract, grant, cooperative agreement, or other transaction, a person make available to the Secretary relevant data related to or resulting from such research and development. Exempts the Secretary's authority to enter into contracts from advertising and advance payment requirements. </p> <p>Allows the Secretary to: (1) use milestone-based awards and payments; (2) make awards to and enter into transactions with highly qualified foreign national persons outside the United States under certain circumstances; (3) establish one or more federally-funded research and development centers or university-affiliated research centers; (4) give priority to the advanced research and development of qualified countermeasures and qualified pandemic or epidemic products that are likely to be safe and effective with respect to the emergency health security needs of children and other vulnerable populations; (5) appoint highly qualified individuals to scientific or professional positions in BARDA without regard to federal provisions governing appointments in the competitive service; (6) appoint special consultants; and (7) accept voluntary and uncompensated services.</p> <p>Requires the Secretary to withhold from disclosure under the Freedom of Information Act specific technical data or scientific information that is created or obtained during the countermeasure and product advanced research and development funded by the Secretary that reveals vulnerabilities of existing medical or public health defenses against biological, chemical, nuclear, or radiological threats.</p> <p>Authorizes appropriations for FY2007-FY2008.</p> <p>Requires the Secretary to establish the National Biodefense Science Board to provide expert advice and guidance to the Secretary on scientific, technical, and other matters of special interest to HHS regarding current and future chemical, biological, nuclear, and radiological agents.</p> <p>(Sec. 4) Includes within the definitions of &quot;qualified countermeasure&quot; and &quot;security countermeasure&quot; an agent to diagnose, mitigate, prevent, or treat harm from organisms that cause an infectious disease. Deems as a qualified countermeasure without further administrative action any countermeasure for a biological agent if the Secretary determines that there is credible evidence that such agent has the potential to cause an epidemic or pandemic that may constitute a public health emergency.</p> <p>(Sec. 5) Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to establish within the Food and Drug Administration (FDA) a team of experts on manufacturing and regulatory activities to provide technical assistance to the manufacturers of qualified countermeasures, security countermeasures, or vaccines if the Secretary determines that a shortage or potential shortage may occur.</p> <p>(Sec, 6) Allows partial payment on a procurement contract for a security countermeasure for significant milestones or a payment to increase manufacturing capacity. Allows procurement contracts to provide: (1) for advance payments for milestones; (2) that the vendor is the sole and exclusive supplier of the product to the government for a specified period if the vendor is able to satisfy the government's needs; (3) that the vendor establish domestic manufacturing capacity of the product to ensure that additional production is available as necessary; (4) dosing and administration requirements for countermeasures; (5) the amount of funding that will be dedicated by the Secretary for countermeasure research and development; and (6) specifications the countermeasure must meet to qualify for procurement under a contract.</p>]]></text>
      </summary>
    </summaries>
    <title>Biodefense and Pandemic Vaccine and Drug Development Act of 2006</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Biodefense and Pandemic Vaccine and Drug Development Act of 2006</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Biodefense and Pandemic Vaccine and Drug Development Act of 2006</title>
      </item>
      <item>
        <titleType>Short Titles as Reported to House</titleType>
        <title>Biodefense and Pandemic Vaccine and Drug Development Act of 2006</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <title>Biodefense and Pandemic Vaccine and Drug Development Act of 2006</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Referred in Senate</type>
        <date>2006-11-13T05:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2006-09-26T04:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2006-09-26T04:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2006-06-06T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-109hr5533ih/xml/BILLS-109hr5533ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2006-11-13</actionDate>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
